TY - JOUR
T1 - Outcomes of Grade III Medial Collateral Ligament Injuries Treated Concurrently With Anterior Cruciate Ligament Reconstruction
T2 - A Multicenter Study
AU - MOON Knee Group
AU - Westermann, Robert W.
AU - Spindler, Kurt P.
AU - Huston, Laura J.
AU - Amendola, Annunziato
AU - Andrish, Jack T.
AU - Brophy, Robert H.
AU - Flanigan, David C.
AU - Jones, Morgan H.
AU - Kaeding, Christopher C.
AU - Marx, Robert G.
AU - Matava, Matthew J.
AU - McCarty, Eric C.
AU - Parker, Richard D.
AU - Reinke, Emily K.
AU - Vidal, Armando F.
AU - Wolcott, Michelle L.
AU - Wright, Rick W.
AU - Wolf, Brian R.
N1 - Funding Information:
The authors report the following potential conflicts of interest or sources of funding: K.S. receives grants from NIH/NIAMS; funding for research from Smith & Nephew Endoscopy and DonJoy Orthopaedics; royalty or consulting fees from the NFL, Cytori, and Mitek; and other support from nPhase. L.H. receives grants from NIH/NIAMS and unrestricted educational gifts from Smith & Nephew Endoscopy and DonJoy Orthopaedics. B.W. is a consultant for ConMed. R.B. receives speaker fees from Arthrex and is a consultant for Magellan. Full ICMJE author disclosure forms are available for this article online, as supplementary material.Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR053684 (K.P.S.)and under Award Number K23AR066133. The content is solely the responsibility of the authors and does not necessarily represent official views of the National Institutes of Health. The project was also supported by the Vanderbilt Sports Medicine Research Fund, which received unrestricted educational gifts from Smith & Nephew Endoscopy and DonJoy Orthopaedics. The authors thank the research coordinators, analysts, and support staff from the Multicenter Orthopaedic Outcomes Network (MOON)sites, including Warren Dunn, M.D. whose efforts related to regulatory, data collection, subject follow-up, data quality control, analyses, and manuscript preparation have made this consortium successful. The MOON Knee Group consists of the following individuals: Annunziato Amendola, M.D. Jack T. Andrish, M.D. Robert H. Brophy, M.D. David C. Flanigan, M.D. Morgan H. Jones, M.D. M.P.H. Christopher C. Kaeding, M.D. Robert G. Marx, M.D. M.Sc. Matthew J. Matava, M.D. Eric C. McCarty, M.D. Richard D. Parker, M.D. Emily K. Reinke, Ph.D. Armando F. Vidal, M.D. Michelle L. Wolcott, M.D. Rick W. Wright, M.D. The authors also thank all the subjects who generously enrolled and participated in this study, as well as Elizabeth Sosic and Brittany Stojsavljevic of the Cleveland Clinic and Laura Withrow of Vanderbilt University with editorial management.
Publisher Copyright:
© 2019 Arthroscopy Association of North America
PY - 2019/5
Y1 - 2019/5
N2 - Purpose: To evaluate differences in repair and nonoperatively managed grade III medial collateral ligament (MCL)injuries during anterior cruciate ligament (ACL)reconstruction. Methods: Patients enrolled in a multicenter prospective longitudinal group who underwent unilateral primary ACL reconstruction between 2002 and 2008 were evaluated. Patients with concomitant grade III MCL injuries treated either operatively or nonoperatively were identified. Concurrent injuries, subsequent surgeries, surgical chronicity, and MCL tear location were analyzed. Patient-reported outcomes were measured at time of ACL reconstruction and 2-year follow-up. Results: Initially, 3,028 patients were identified to have undergone primary ACL reconstruction during the time frame; 2,586 patients completed 2-year follow-up (85%). Grade III MCL tears were documented in 1.1% (27 of 2,586): 16 operatively managed patients and 11 nonoperatively treated MCLs during ACL reconstruction. The baseline Knee Injury and Osteoarthritis Outcome Score (KOOS)and International Knee Documentation Committee scores were lower in patients who underwent operative MCL treatment. Reoperation rates for arthrofibrosis were 19% after repair and 9% after conservative management (P =.48). At 2 years, both groups significantly improved; however, the nonoperative MCL group maintained superior patient-reported outcomes in terms of minimal clinically important differences, but these differences did not reach statistical significance (KOOS sports/recreation [88.2 vs 74.4, P =.10], KOOS knee-related quality of life [81.3 vs 68.4, P =.13], and International Knee Documentation Committee [87.6 vs 76.0, P =.14]). Tibial-sided MCL injuries were associated with clinically inferior baseline scores compared with femoral-sided MCL (KOOS knee-related quality of life, 34.4 vs 18.5, P =.09), but these differences resolved by 2 years. Surgical chronicity did not influence 2-year outcome. Conclusions: Both operative and nonoperative management of MCL tears in our patient group demonstrated clinical improvements between study enrollment and 2-year follow-up. MCL surgery during ACL reconstruction was assigned to patients with worse symptoms at enrollment and was associated with worse outcomes at 2 years. A subset of patients with severe combined ACL and medial knee injuries may benefit from operative management; however, that population has yet to be defined. Level of Evidence: Level III, retrospective cohort.
AB - Purpose: To evaluate differences in repair and nonoperatively managed grade III medial collateral ligament (MCL)injuries during anterior cruciate ligament (ACL)reconstruction. Methods: Patients enrolled in a multicenter prospective longitudinal group who underwent unilateral primary ACL reconstruction between 2002 and 2008 were evaluated. Patients with concomitant grade III MCL injuries treated either operatively or nonoperatively were identified. Concurrent injuries, subsequent surgeries, surgical chronicity, and MCL tear location were analyzed. Patient-reported outcomes were measured at time of ACL reconstruction and 2-year follow-up. Results: Initially, 3,028 patients were identified to have undergone primary ACL reconstruction during the time frame; 2,586 patients completed 2-year follow-up (85%). Grade III MCL tears were documented in 1.1% (27 of 2,586): 16 operatively managed patients and 11 nonoperatively treated MCLs during ACL reconstruction. The baseline Knee Injury and Osteoarthritis Outcome Score (KOOS)and International Knee Documentation Committee scores were lower in patients who underwent operative MCL treatment. Reoperation rates for arthrofibrosis were 19% after repair and 9% after conservative management (P =.48). At 2 years, both groups significantly improved; however, the nonoperative MCL group maintained superior patient-reported outcomes in terms of minimal clinically important differences, but these differences did not reach statistical significance (KOOS sports/recreation [88.2 vs 74.4, P =.10], KOOS knee-related quality of life [81.3 vs 68.4, P =.13], and International Knee Documentation Committee [87.6 vs 76.0, P =.14]). Tibial-sided MCL injuries were associated with clinically inferior baseline scores compared with femoral-sided MCL (KOOS knee-related quality of life, 34.4 vs 18.5, P =.09), but these differences resolved by 2 years. Surgical chronicity did not influence 2-year outcome. Conclusions: Both operative and nonoperative management of MCL tears in our patient group demonstrated clinical improvements between study enrollment and 2-year follow-up. MCL surgery during ACL reconstruction was assigned to patients with worse symptoms at enrollment and was associated with worse outcomes at 2 years. A subset of patients with severe combined ACL and medial knee injuries may benefit from operative management; however, that population has yet to be defined. Level of Evidence: Level III, retrospective cohort.
UR - http://www.scopus.com/inward/record.url?scp=85062810162&partnerID=8YFLogxK
U2 - 10.1016/j.arthro.2018.10.138
DO - 10.1016/j.arthro.2018.10.138
M3 - Article
C2 - 30878328
AN - SCOPUS:85062810162
SN - 0749-8063
VL - 35
SP - 1466
EP - 1472
JO - Arthroscopy - Journal of Arthroscopic and Related Surgery
JF - Arthroscopy - Journal of Arthroscopic and Related Surgery
IS - 5
ER -